STOCK TITAN

State Street Corporation (NYSE: CATX) reports 6.05M-share, 5.3% stake in Perspective

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

State Street Corporation reported beneficial ownership of common stock of Perspective Therapeutics, Inc.. State Street reported beneficially owning 6,051,771 shares of common stock, representing 5.3% of the class. All reported voting and dispositive authority is shared, with 5,942,306 shares subject to shared voting power and 6,051,771 shares subject to shared dispositive power, and no shares subject to sole voting or dispositive power.

The filing identifies subsidiaries involved in the holdings, including SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company, each classified as an investment adviser. The filing states that no other person is known to have rights to dividends or sale proceeds relating to more than 5% of the class.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 6,051,771 shares Common stock of Perspective Therapeutics beneficially owned by State Street Corporation
Percent of class owned 5.3% Percentage of Perspective Therapeutics common stock class beneficially owned
Shared voting power 5,942,306 shares Shares over which State Street reports shared power to vote or direct the vote
Shared dispositive power 6,051,771 shares Shares over which State Street reports shared power to dispose or direct disposition
Sole voting power 0 shares Shares of Perspective Therapeutics with sole voting authority reported by State Street
Sole dispositive power 0 shares Shares of Perspective Therapeutics with sole dispositive authority reported by State Street
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 6051771.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared Voting Power 5,942,306.00 7 | Sole Dispositive Power"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 6,051,771.00 9 6,051,771.00"
Investment Company Act of 1940 regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
investment adviser (IA) financial
"SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS"
An investment adviser (IA) is a person or firm that provides personalized guidance on buying, selling, or holding investments and often manages client portfolios for a fee. Investors should care because an IA has a legal duty to act in the client's best interest—think of them as a navigator who plans and steers your financial journey—so their advice, fee structure and potential conflicts can directly affect returns and financial risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Perspective Therapeutics (CATX) shares does State Street own?

State Street Corporation reports beneficial ownership of 5.3% of Perspective Therapeutics’ common stock, representing 6,051,771 shares. This ownership is reported on a Schedule 13G, indicating a passive investment rather than an activist position.

How many CATX shares does State Street have voting power over?

State Street reports shared voting power over 5,942,306 shares of Perspective Therapeutics common stock and no sole voting power. Shared voting power means voting decisions are made jointly with affiliated entities rather than by State Street alone.

What is the difference between State Street’s voting and dispositive power in CATX?

State Street reports shared voting power over 5,942,306 shares and shared dispositive power over 6,051,771 shares of Perspective Therapeutics. Dispositive power relates to the ability to sell or otherwise dispose of the shares, which slightly exceeds the shares over which votes can be cast.

Which State Street subsidiaries are involved in managing the CATX position?

The filing identifies SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company as involved subsidiaries, each classified as an investment adviser (IA) in relation to the Perspective Therapeutics holdings.

Does any other person have more than 5% economic interest in CATX through State Street’s holdings?

The Schedule 13G states “NOT APPLICABLE” for ownership on behalf of another person. It indicates no other person is identified as having the right to receive dividends or sale proceeds relating to more than 5% of the Perspective Therapeutics common stock class.

Is State Street part of a group filing for its CATX ownership?

The filing notes “NOT APPLICABLE” for group identification and dissolution, indicating that the reported 5.3% ownership of Perspective Therapeutics is not being reported as part of a Schedule 13G group arrangement under the referenced rules.





46489V302

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:08/07/2026